Invention Grant
- Patent Title: RORgammaT inhibitors
- Patent Title (中): RORGAMMA抑制剂
-
Application No.: US13983818Application Date: 2012-02-10
-
Publication No.: US09095583B2Publication Date: 2015-08-04
- Inventor: Willem Frederik Johan Karstens , Mario Van Der Stelt , Jos Cals , Rita Corte Real Goncalves Azevedo , Kenneth Jay Barr , Hongjun Zhang , Richard Thomas Beresis , Dongshan Zhang , Xiaobang Duan
- Applicant: Willem Frederik Johan Karstens , Mario Van Der Stelt , Jos Cals , Rita Corte Real Goncalves Azevedo , Kenneth Jay Barr , Hongjun Zhang , Richard Thomas Beresis , Dongshan Zhang , Xiaobang Duan
- Applicant Address: US NJ Rahway NL Haarlem
- Assignee: Merck Sharp & Dohme Corp.,Merck Sharp & Dohme B.V.
- Current Assignee: Merck Sharp & Dohme Corp.,Merck Sharp & Dohme B.V.
- Current Assignee Address: US NJ Rahway NL Haarlem
- Agency: Covington & Burling LLP
- Agent Andrea G. Reister; Melody Wu
- Priority: EP11154188 20110211
- International Application: PCT/CN2012/071017 WO 20120210
- International Announcement: WO2012/106995 WO 20120816
- Main IPC: C07D401/10
- IPC: C07D401/10 ; A61K31/4353 ; A61K31/4439 ; C07D231/56 ; C07D401/06 ; C07D401/12 ; C07D403/10 ; C07D409/14 ; C07D413/12 ; C07D413/14 ; C07D471/04 ; A61K31/416 ; A61K31/4245 ; A61K31/437 ; A61K31/4709 ; A61K45/06
Abstract:
The present invention relates to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or condition.
Public/Granted literature
- US20140038942A1 RORgammaT INHIBITORS Public/Granted day:2014-02-06
Information query
